Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- THNR
- Price
- 24.51
- Stock movement up
- +0.39 (1.74%)
- Company name
- Amplify Weight Loss Drug & Treatment ETF
- Exchange
- (NYSE ARCA ,
- Currency
- USD )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 0.96%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -14.14%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-03
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 0.22 |
| Dividend yield | 0.96% |
| Payout frequency | Annual |
| Maximum yield | 1.17% |
| Average yield | 0.50% |
| Minimum yield | - |
| Discount to avg yield | 47.89% |
| Upside potential | 91.89% |
| Yield as % of max yield | 82.15% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.96% |
| Current yield distribution | 36.45% |
| Yield at 100% (Min) | - |
| Yield at 90% | - |
| Yield at 80% | - |
| Yield at 50% (Median) | 0.92% |
| Yield at 20% | 0.98% |
| Yield at 10% | 1.01% |
| Yield at 0% (Max) | 1.17% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | - |
| Dividend per share | 0.22 |
| Payout frequency | Annual |
| Ex-div date | 30 Dec 2024 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| THNR | S&P500 | |
| DGR MR | - | -13.74% |
| DGR TTM | - | 6.60% |
| DGR 3 years | - | 5.24% |
| DGR 5 years | - | 5.40% |
| DGR 10 years | - | 7.07% |
| DGR 15 years | - | 6.12% |
| Time since last change announced | 529 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 23.00 |
| Daily high | 23.00 |
| Daily low | 22.74 |
| Daily Volume | 3K |
| All-time high | 28.19 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.22 |
| Ex-div date | 30 Dec 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| THNR | S&P500 | |
| Current price drop from All-time high | -13.07% | - |
| Highest price drop | -33.15% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -13.42% | -2.76% |
| Avg time to new high | 13 days | 5 days |
| Max time to new high | 240 days | 89 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Mid-cap
Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Employees
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner